AMEH - Apollo Medical Holdings Inc Stock Price, Fair Value and News

37.43USD-0.02 (-0.05%)Market Closed

Market Summary

USD37.43-0.02

Market Closed

-0.05%

AMEH Stock Price

View Fullscreen

AMEH RSI Chart

AMEH Valuation

Market Cap

2.1B

Price/Earnings (Trailing)

34.17

Price/Sales (Trailing)

1.5

EV/EBITDA

16.49

Price/Free Cashflow

52.26

AMEH Price/Sales (Trailing)

AMEH Profitability

EBT Margin

6.48%

Return on Equity

9.89%

Return on Assets

6.51%

Free Cashflow Yield

1.91%

AMEH Fundamentals

AMEH Revenue

Revenue (TTM)

1.4B

Rev. Growth (Yr)

20%

Rev. Growth (Qtr)

1.4%

AMEH Earnings

Earnings (TTM)

60.7M

Earnings Growth (Yr)

431.44%

Earnings Growth (Qtr)

-43.99%

Breaking Down AMEH Revenue

Last 7 days

-1.2%

Last 30 days

-5.6%

Last 90 days

2.0%

Trailing 12 Months

-0.3%

How does AMEH drawdown profile look like?

AMEH Financial Health

Current Ratio

2.11

Debt/Equity

0.42

Debt/Cashflow

0.26

AMEH Investor Care

Buy Backs (1Y)

3.50%

Diluted EPS (TTM)

1.29

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	1.2B	1.3B	1.3B	1.4B
2022	861.1M	955.2M	1.0B	1.1B
2021	698.1M	708.6M	755.6M	773.9M
2020	630.0M	695.2M	705.7M	717.4M
2019	491.7M	499.1M	488.5M	560.6M
2018	394.9M	476.0M	545.6M	519.9M
2017	128.0M	157.2M	239.7M	356.4M
2016	44.0M	46.2M	49.5M	54.5M
2015	33.0M	39.1M	38.8M	41.8M
2014	10.8M	12.1M	20.9M	25.7M
2013	6.6M	7.1M	9.3M	10.3M
2012	5.1M	5.7M	6.3M	6.8M
2011	3.9M	4.2M	4.5M	4.8M
2010	0	0	0	0

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224

Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Apollo Medical Holdings Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Jan 23, 2024	kumar dinesh m.	acquired	-	-	150,395	see remarks
Dec 15, 2023	marsh linda	acquired	-	-	3,650	-
Dec 15, 2023	mazdyasni matthew	acquired	-	-	4,750	-
Dec 15, 2023	vong john	acquired	-	-	14,352	chief accounting officer
Dec 15, 2023	dai, weili	acquired	-	-	3,650	-
Dec 15, 2023	chiang john	acquired	-	-	4,750	-
Dec 15, 2023	schmidt david	acquired	-	-	5,750	-
Dec 15, 2023	lam thomas s.	acquired	-	-	90,000	president and co-ceo
Dec 15, 2023	sim kenneth t.	acquired	-	-	90,000	executive chairman
Dec 15, 2023	kitayama mitchell w	acquired	-	-	6,750	-

Which funds bought or sold AMEH recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 22, 2024	MetLife Investment Management, LLC	unchanged	-	168,415	865,810	0.01%
Apr 19, 2024	Maryland State Retirement & Pension System	unchanged	-	-10,872	567,496	0.01%
Apr 19, 2024	State of Alaska, Department of Revenue	reduced	-2.35	71,000	1,077,000	0.01%
Apr 18, 2024	Capital Advisors, Ltd. LLC	unchanged	-	-	-	-%
Apr 18, 2024	SJS Investment Consulting Inc.	unchanged	-	14.00	168	-%
Apr 18, 2024	FARMERS & MERCHANTS INVESTMENTS INC	unchanged	-	100	1,134	-%
Apr 18, 2024	SteelPeak Wealth, LLC	reduced	-1.48	2,078,880	28,014,700	1.41%
Apr 17, 2024	GUIDANCE CAPITAL, INC	new	-	465,807	465,807	0.17%
Apr 16, 2024	Arlington Trust Co LLC	sold off	-100	-1,264	-	-%
Apr 15, 2024	NorthCrest Asset Manangement, LLC	reduced	-0.01	750,381	8,547,610	0.29%

Are Funds Buying or Selling AMEH?

Are funds buying AMEH calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own AMEH

No. of Funds

Unveiling Apollo Medical Holdings Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 13, 2024	vanguard group inc	8.66%	5,049,928	SC 13G/A
Jan 23, 2024	blackrock inc.	13.5%	6,498,075	SC 13G/A
Nov 17, 2023	allied physicians of california, a profession medical corp	12.9%	7,132,698	SC 13D/A
Feb 09, 2023	vanguard group inc	7.83%	4,438,955	SC 13G/A
Jan 26, 2023	blackrock inc.	11.5%	6,514,440	SC 13G/A
Jan 20, 2023	blackrock inc.	11.5%	6,514,440	SC 13G/A
Feb 09, 2022	vanguard group inc	7.02%	3,897,315	SC 13G
Jan 28, 2022	blackrock inc.	10.7%	5,960,508	SC 13G/A
Oct 08, 2021	blackrock inc.	10.6%	5,867,352	SC 13G
Jul 08, 2021	allied physicians of california, a profession medical corp	20.0%	10,993,301	SC 13D/A

Recent SEC filings of Apollo Medical Holdings Inc

View All Filings

Date Filed	Form Type	Document
Apr 22, 2024	4	Insider Trading
Apr 19, 2024	4	Insider Trading
Apr 09, 2024	PRE 14A	PRE 14A
Apr 05, 2024	8-K	Current Report
Apr 04, 2024	4	Insider Trading
Apr 04, 2024	4	Insider Trading
Apr 02, 2024	8-K	Current Report
Mar 11, 2024	8-K	Current Report
Feb 29, 2024	8-K	Current Report
Feb 29, 2024	10-K	Annual Report

Peers (Alternatives to Apollo Medical Holdings Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
UNH	448.5B	371.6B	-0.74%	-0.51%	20.04	1.21	14.64%	11.24%
CI	103.1B	195.3B	0.26%	37.72%	19.19	0.53	8.17%	-20.79%
CVS	86.2B	357.8B	-12.72%	-6.73%	10.32	0.24	10.95%	93.52%
HCA	84.5B	65.0B	-3.19%	11.59%	16.12	1.3	7.86%	-7.11%
CNC	40.6B	154.0B	-1.43%	12.08%	15.01	0.26	6.54%	124.79%
DVA	11.7B	12.1B	-0.12%	51.97%	16.99	0.97	4.57%	23.40%
UHS	11.4B	14.3B	-8.62%	17.22%	15.93	0.8	6.59%	6.24%
MID-CAP
CHE	9.3B	2.3B	-4.84%	8.83%	34.25	4.12	6.06%	9.17%
ACHC	6.5B	2.9B	-7.52%	-4.24%	-301.31	2.23	12.20%	-107.93%
AMN	2.2B	3.8B	-10.62%	-35.16%	10.27	0.57	-27.73%	-52.50%
AMEH	2.1B	1.4B	-5.65%	-0.29%	34.17	1.5	21.19%	34.42%
SMALL-CAP
ADUS	1.5B	1.1B	-8.44%	-16.43%	24.6	1.45	11.31%	35.83%
BKD	1.3B	3.0B	7.61%	59.68%	-6.94	0.44	6.74%	20.73%
BEAT	54.5M	-	-3.27%	-3.72%	-3.72	-	-	-12.94%
AMS	18.9M	21.3M	13.26%	5.28%	35.51	0.89	8.00%	-62.25%

Apollo Medical Holdings Inc News

Latest updates

Apollo Medical Holdings Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Income Statement (Quarterly)																					(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Revenue	1.4%	353	348	348	337	294	317	270	263	195	227	176	176	177	180	165	195	165	179	156	130	96.00
Costs and Expenses	15.5%	357	309	321	315	282	267	254	237	193	174	155	154	137	143	152	189	161	168	146	115	99.00
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	168	146	115	99.00
S&GA Expenses	29.0%	38.00	29.00	24.00	21.00	24.00	21.00	20.00	12.00	17.00	22.00	14.00	9.00	9.00	16.00	12.00	-	12.00	11.00	8.00	12.00	10.00
EBITDA Margin	-8.6%	0.09*	0.10*	0.10*	0.09*	0.10*	0.07*	0.03*	0.11*	0.13*	0.20*	0.27*	0.32*	-	-	-	-	-	-	-	-	-
Interest Expenses	43.5%	5.00	4.00	4.00	3.00	3.00	2.00	2.00	1.00	1.00	1.00	2.00	2.00	1.00	2.00	3.00	-	3.00	3.00	1.00	0.00	0.00
Income Taxes	-89.9%	1.00	10.00	14.00	7.00	11.00	17.00	5.00	7.00	-4.28	-0.28	28.00	8.00	13.00	11.00	32.00	-	2.00	2.00	4.00	4.00	-1.41
Earnings Before Taxes	-97.6%	1.00	38.00	31.00	19.00	10.00	41.00	17.00	18.00	-22.43	-5.50	84.00	21.00	24.00	36.00	113	6.00	5.00	0.00	14.00	15.00	-3.86
EBT Margin	-13.4%	0.06*	0.07*	0.08*	0.07*	0.08*	0.05*	0.01*	0.09*	0.10*	0.16*	0.23*	0.28*	-	-	-	-	-	-	-	-	-
Net Income	-44.0%	12.00	22.00	13.00	13.00	-3.73	23.00	12.00	14.00	12.00	34.00	10.00	12.00	10.00	17.00	7.00	6.00	4.00	7.00	4.00	4.00	0.00
Net Income Margin	30.3%	0.04*	0.03*	0.04*	0.04*	0.04*	0.06*	0.08*	0.08*	0.09*	0.09*	0.07*	0.07*	-	-	-	-	-	-	-	-	-
Free Cashflow	8.3%	12.00	11.00	14.00	2.00	84.00	-39.08	8.00	7.00	-14.99	42.00	14.00	10.00	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Assets	-13.0%	933	1,073	1,027	999	966	955	967	923	867	871	896	843	817	814	833	724	729	750	568	521	513
Current Assets	-3.1%	462	476	465	455	428	446	468	445	404	427	472	370	339	367	381	318	329	321	168	177	173
Cash Equivalents	7.3%	294	274	294	275	288	184	234	238	233	205	177	206	194	166	152	81.00	104	230	53.00	93.00	108
Net PPE	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	12.00	12.00	12.00	13.00
Goodwill	1.2%	279	276	274	269	269	251	247	246	246	237	232	232	232	239	239	239	239	237	209	186	186
Liabilities	14.2%	523	458	444	434	408	410	447	397	357	346	356	382	372	386	414	369	368	382	163	126	106
Current Liabilities	7.7%	219	203	186	173	149	156	185	156	115	115	126	123	115	131	153	107	105	105	78.00	88.00	72.00
Long Term Debt	25.6%	259	206	205	205	203	199	199	183	183	183	183	227	230	226	230	230	232	234	-	-	-
LT Debt, Current	552.0%	20.00	3.00	3.00	1.00	1.00	3.00	2.00	2.00	1.00	0.00	0.00	12.00	11.00	10.00	10.00	10.00	10.00	10.00	-	-	-
LT Debt, Non Current	25.6%	259	206	205	205	203	199	199	183	183	183	183	227	230	226	230	230	232	234	-	-	-
Shareholder's Equity	3.5%	614	594	570	551	543	504	480	473	454	435	399	347	329	229	208	198	192	192	186	182	182
Retained Earnings	5.4%	243	231	209	196	182	186	163	151	137	125	90.00	80.00	68.00	60.00	43.00	36.00	32.00	25.00	21.00	18.00	18.00
Additional Paid-In Capital	2.2%	371	363	357	353	360	315	311	316	311	306	306	266	261	169	164	161	160	166	164	163	163
Shares Outstanding	0.5%	47.00	47.00	47.00	46.00	47.00	45.00	45.00	45.00	45.00	44.00	44.00	43.00	-	-	-	-	-	-	-	-	-
Minority Interest	-39.1%	2.00	4.00	4.00	3.00	2.00	3.00	6.00	6.00	6.00	4.00	3.00	1.00	0.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00
Float	-	-	-	1,300	-	-	-	1,500	-	-	-	2,400	-	-	-	504	-	-	-	480	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Cashflow From Operations	25.3%	19,300	15,405	25,802	7,720	84,939	-35,870	9,021	24,038	-12,190	51,239	21,334	9,952	-2,601	36,189	21,868	-9,293	3,588	32,102	-18,050	-3,967	-6,368
Share Based Compensation	52.1%	8,676	5,706	4,213	3,445	5,624	3,502	3,920	3,055	2,423	1,420	1,556	1,346	825	600	900	1,058	541	330	331	345	202
Cashflow From Investing	67.2%	-11,427	-34,875	-5,186	-14,035	13,201	-8,086	7,497	-19,725	39,084	-12,742	-10,494	692	29,096	-753	68,093	-943	-120,267	-10,117	-50,135	-112	-4,934
Cashflow From Financing	2451.6%	11,993	-510	-963	-7,099	5,871	-6,251	-20,237	532	1,435	-11,016	-39,429	1,262	647	-21,795	-18,487	-12,061	-10,376	152,076	31,441	-9,810	-5,802
Dividend Payments	4100.0%	59,808	1,424	722	120	1,354	120	11,378	1,178	-	9,979	21,106	4.00	1,186	19,946	-	9,934	1,047	49,728	942	10,000	4,216
Buy Backs	-100.0%	-	150	9,539	-	-423	168	9,300	230	-	2,758	2,639	342	-1,022	771	362	426	7,530	-	-	40.00	5,047

AMEH Income Statement

2023-12-31

CONSOLIDATED STATEMENTS OF INCOME - USD ($) $ in Thousands	12 Months Ended
CONSOLIDATED STATEMENTS OF INCOME - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Revenue
Total revenue	$ 1,386,661	$ 1,144,163	$ 773,915
Operating expenses
Cost of services, excluding depreciation and amortization	1,171,703	944,685	596,142
General and administrative expenses	112,597	77,670	62,077
Depreciation and amortization	17,748	17,543	17,517
Total expenses	1,302,048	1,039,898	675,736
Income from operations	84,613	104,265	98,179
Other income (expense)
Income (loss) from equity method investments	5,579	5,622	(4,306)
Gain on sale of equity method investment	0	0	2,193
Interest expense	(16,102)	(7,920)	(5,394)
Interest income	14,208	1,976	1,571
Unrealized loss on investments	(4,581)	(21,271)	(10,745)
Other income (loss)	6,121	3,944	(3,750)
Total other income (expense), net	5,225	(17,649)	(20,431)
Income before provision for income taxes	89,838	86,616	77,748
Provision for income taxes	31,989	40,875	31,693
Net income	57,849	45,741	46,055
Net (loss) income attributable to noncontrolling interests	(2,868)	570	(22,868)
Net income attributable to Astrana Health, Inc.	$ 60,717	$ 45,171	$ 68,923
Earnings per share – basic (in dollars per share)	$ 1.30	$ 1.00	$ 1.57
Earnings per share – diluted (in dollars per share)	$ 1.29	$ 0.99	$ 1.52
Capitation, net
Revenue
Total revenue	$ 1,215,614	$ 930,131	$ 593,224
Risk pool settlements and incentives
Revenue
Total revenue	63,468	117,254	111,627
Management fee income
Revenue
Total revenue	38,677	41,094	35,959
Fee-for-service, net
Revenue
Total revenue	59,658	49,517	26,564
Other revenue
Revenue
Total revenue	$ 9,244	$ 6,167	$ 6,541

AMEH Balance Sheet

2023-12-31

CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands

Dec. 31, 2023

Dec. 31, 2022

Current assets

Cash and cash equivalents

$ 293,807

$ 288,027

Investment in marketable securities

2,498

5,567

Income taxes receivable

10,657

Other receivables

1,335

1,834

Prepaid expenses and other current assets

17,450

14,798

Total current assets

461,507

428,125

Non-current assets

Land, property and equipment, net

7,171

108,536

Intangible assets, net

71,648

76,861

Goodwill

278,831

269,053

Income taxes receivable

15,943

Loans receivable, non-current

26,473

Investments in other entities – equity method

25,774

40,299

Investments in privately held entities

6,396

2,396

Restricted cash

345

Operating lease right-of-use assets

37,396

20,444

Other assets

1,877

4,556

Total non-current assets

471,854

538,088

Total assets

^[1]

933,361

966,213

Current liabilities

Accounts payable and accrued expenses

59,949

49,562

Fiduciary accounts payable

7,737

8,065

Medical liabilities

106,657

81,255

Income taxes payable

4,279

Dividend payable

638

664

Finance lease liabilities

646

594

Operating lease liabilities

4,607

3,572

Current portion of long-term debt

19,500

619

Other liabilities

18,940

Total current liabilities

218,674

148,610

Non-current liabilities

Deferred tax liability

4,072

14,217

Finance lease liabilities, net of current portion

1,033

1,275

Operating lease liabilities, net of current portion

36,289

19,915

Long-term debt, net of current portion and deferred financing costs

258,939

203,389

Other long-term liabilities

3,586

20,260

Total non-current liabilities

303,919

259,056

Total liabilities

^[1]

522,593

407,666

Commitments and contingencies (Note 14)

Mezzanine (deficit) equity

Non-controlling interest in Allied Physicians of California, a Professional Medical Corporation (“APC”)

(205,883)

14,237

Stockholders’ equity

Common stock, par value $0.001; 100,000,000 shares authorized, 46,843,743 and 46,575,699 shares outstanding, excluding 10,584,340 and 10,299,259 treasury shares, at December 31, 2023 and 2022, respectively

Additional paid-in capital

371,037

360,097

Retained earnings

243,134

182,417

Stockholders' equity attributable to parent

614,218

542,561

Non-controlling interest

2,433

1,749

Total stockholders’ equity

616,651

544,310

Total liabilities, mezzanine equity (deficit), and stockholders’ equity

933,361

966,213

Series A Preferred Stock

Stockholders’ equity

Preferred stock

Series B Preferred Stock

Stockholders’ equity

Preferred stock

Nonrelated Party

Current assets

Receivables, net

76,780

49,631

Loans receivable, net

996

Related Party

Current assets

Receivables, net

58,980

65,147

Loans receivable, net

$ 0

$ 2,125

[1]

The Company’s consolidated balance sheets include the assets and liabilities of its consolidated VIEs. The consolidated balance sheets include total assets that can be used only to settle obligations of the Company’s consolidated VIEs totaling $540.8 million and $579.8 million as of December 31, 2023 and December 31, 2022, respectively, and total liabilities of the Company’s consolidated VIEs for which creditors do not have recourse to the general credit of the primary beneficiary of $146.0 million and $149.6 million as of December 31, 2023 and December 31, 2022, respectively. These VIE balances do not include $273.2 million of investment in affiliates and $107.3 million of amounts due to affiliates as of December 31, 2023 and $304.8 million of investment in affiliates and $11.6 million of amounts due from affiliates as of December 31, 2022 as these are eliminated upon consolidation and not presented within the consolidated balance sheets. See Note 18 – “Variable Interest Entities (VIEs)” for further detail.

About Apollo Medical Holdings Inc

Apollo Medical Holdings, Inc., a physician-centric technology-powered healthcare company, provides medical care services in the United States. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients in California. The company was incorporated in 1985 and is headquartered in Alhambra, California.

CEO	Dr. Thomas S. Lam M.D., M.P.H.
WEBSITE	apollomed.net
INDUSTRY	Healthcare Plans
EMPLOYEES	1362

Apollo Medical Holdings Inc Frequently Asked Questions

What is the ticker symbol for Apollo Medical Holdings Inc? What does AMEH stand for in stocks?

AMEH is the stock ticker symbol of Apollo Medical Holdings Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Apollo Medical Holdings Inc (AMEH)?

As of Tue Apr 23 2024, market cap of Apollo Medical Holdings Inc is 2.07 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of AMEH stock?

You can check AMEH's fair value in chart for subscribers.

What is the fair value of AMEH stock?

You can check AMEH's fair value in chart for subscribers. The fair value of Apollo Medical Holdings Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Apollo Medical Holdings Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for AMEH so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Apollo Medical Holdings Inc a good stock to buy?

The fair value guage provides a quick view whether AMEH is over valued or under valued. Whether Apollo Medical Holdings Inc is cheap or expensive depends on the assumptions which impact Apollo Medical Holdings Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for AMEH.

What is Apollo Medical Holdings Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue Apr 23 2024, AMEH's PE ratio (Price to Earnings) is 34.17 and Price to Sales (PS) ratio is 1.5. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. AMEH PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Apollo Medical Holdings Inc's stock?

In the past 10 years, Apollo Medical Holdings Inc has provided 0.211 (multiply by 100 for percentage) rate of return.